In consultation: Guidance and quality standards
Showing 1 to 1 of 1
| Title | Consultation | Type | Consultation end date |
|---|---|---|---|
| Tirzepatide for reducing the risk of major adverse cardiovascular events in people with type 2 diabetes and cardiovascular disease ID6733 | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators | Technology appraisal guidance |